dc.contributor.author | Wisløff, Torbjørn | |
dc.contributor.author | White, Richard Aubrey | |
dc.contributor.author | Dalgard, Olav | |
dc.contributor.author | Amundsen, Ellen Johanna | |
dc.contributor.author | Meijerink, Hinta | |
dc.contributor.author | Løvlie, Astrid Louise | |
dc.contributor.author | Kløvstad, Hilde | |
dc.date.accessioned | 2018-07-30T12:32:39Z | |
dc.date.available | 2018-07-30T12:32:39Z | |
dc.date.created | 2018-04-25T14:32:06Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | PharmacoEconomics (Auckland). 2018, 36 (5), 591-601. | |
dc.identifier.issn | 1170-7690 | |
dc.identifier.uri | http://hdl.handle.net/11250/2506827 | |
dc.language.iso | eng | |
dc.relation.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906515/ | |
dc.title | Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 591-601 | |
dc.source.volume | 36 | |
dc.source.journal | PharmacoEconomics (Auckland) | |
dc.source.issue | 5 | |
dc.identifier.doi | 10.1007/s40273-017-0604-3 | |
dc.identifier.cristin | 1581614 | |
cristin.unitcode | 7502,4,19,0 | |
cristin.unitcode | 7502,3,4,0 | |
cristin.unitcode | 7502,4,20,0 | |
cristin.unitcode | 7502,4,12,0 | |
cristin.unitname | Infeksjonsepidemiologi og modellering | |
cristin.unitname | Rusmiddelbruk | |
cristin.unitname | Smittevernregistre | |
cristin.unitname | Tuberkulose, blod- og seksuell smitte | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 | |